TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bionordika AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
43,483
|
44,901
|
54,109 |
| Financial expenses |
440
|
780
|
690 |
| Earnings before taxes |
2,354
|
3,564
|
11,051 |
| Total assets |
20,322
|
18,240
|
26,660 |
| Current assets |
19,446
|
17,558
|
26,202 |
| Current liabilities |
11,904
|
10,752
|
18,862 |
| Equity capital |
7,187
|
7,367
|
7,605 |
| - share capital |
102
|
102
|
102 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
40.4%
|
28.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.4%
|
7.9%
|
20.4% |
| Return on assets (ROA) |
13.7%
|
23.8%
|
44.0% |
| Current ratio |
163.4%
|
163.3%
|
138.9% |
| Return on equity (ROE) |
32.8%
|
48.4%
|
145.3% |
| Change turnover |
-1,418
|
-9,208
|
-13,879 |
| Change turnover % |
-3%
|
-17%
|
-20% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.